Kathleen Rose
Nurse Practitioner · Canandaigua, NYNPI 1871926204
Payments from drug & device makers
Across 931 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Teva Pharmaceuticals USA, Inc.$1K
- Lundbeck LLC$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $6K from 17 others
What the payments were for
- Food & beverage$17,32799%
- Education$1181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 150 | $3,160 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 139 | $2,922 |
| Teva Pharmaceuticals USA, Inc. | 77 | $1,355 |
| Lundbeck LLC | 70 | $1,349 |
| Alkermes, Inc. | 60 | $1,201 |
| Otsuka America Pharmaceutical, Inc. | 61 | $1,134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 77 | $1,121 |
| Sunovion Pharmaceuticals Inc. | 61 | $1,069 |
| Vanda Pharmaceuticals Inc. | 37 | $807 |
| Neurocrine Biosciences, Inc. | 50 | $788 |
| Axsome Therapeutics, Inc. | 48 | $780 |
| Supernus Pharmaceuticals, Inc. | 44 | $726 |
| Johnson & Johnson | 15 | $250 |
| Avanir Pharmaceuticals, Inc. | 7 | $172 |
| Idorsia Pharmaceuticals US Inc | 8 | $148 |
| Bausch Health US, LLC | 8 | $147 |
| Corium, LLC | 7 | $85 |
| E.r. Squibb & Sons, L.L.C. | 3 | $61 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Merck | 3 | $45 |
| Noven Therapeutics, LLC | 2 | $40 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,445 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 24 | $190,296 |
| VraylarCariprazine Hcl | 84 | $144,734 |
| CaplytaLumateperone Tosylate | 49 | $85,080 |
| RexultiBrexpiprazole | 25 | $35,188 |
| EmsamSelegiline | 12 | $23,044 |
| TrintellixVortioxetine Hydrobromide | 22 | $19,037 |
| Lisdexamfetamine Dimesylate | 42 | $11,423 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $7,836 |
| Bupropion XlBupropion Hcl | 192 | $5,169 |
| Lurasidone Hcl | 17 | $4,089 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 61 | $3,773 |
| QelbreeViloxazine Hcl | 11 | $3,632 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 96 | $3,344 |
| Vilazodone Hcl | 13 | $2,954 |
| Lamotrigine ErLamotrigine | 11 | $2,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $788 | $190,29624 claims |
| AbbVieVraylar | $3,160 | $144,73484 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,922 | $85,08049 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,134 | $35,18825 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $1,121 | $26,87333 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $726 | $3,63211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Canandaigua
- Carla JungquistCanandaigua$28K
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.